| Product Name | MF | CAS | Details |
|---|
| 2'-O-Methyl-2-thiouridine | C10H14N2O5S | 113886-72-9 | Details |
| IgG (Fc) Goat Polyclonal Antibody | Details |
| 1-(1,2,4-Oxadiazol-5-yl)-2-phenylethan-1-amine, trifluoroacetic acid | 1955557-04-6 | Details |
| 1-[(tert-Butoxy)carbonyl]-4,4-dimethylpiperidine-3-carboxylic acid | C13H23NO4 | 1798843-57-8 | Details |
| Spiro[2.5]octan-6-one | C8H12O | 15811-21-9 | Details |
| 1-Bromo-4-methoxycyclohexane | C7H13BrO | 1567059-60-2 | Details |
| AN3485 hydrochloride | C14H14BCl2NO3 | 1213786-72-1 | Details |
| 1-Bromo-3-(phenoxymethyl)benzene | C13H11BrO | 20600-29-7 | Details |
| Phenylmalonic acid | C9H8O4 | 2613-89-0 | Details |
| 4-(4'-Benzamide)piperidine | C12H16N2O | 886362-49-8 | Details |
| Des[5-(2-dimethylamino)ethyl] diltiazem | C18H17NO4S | 87447-47-0 | Details |
| 5-Chloro-2-methylisonicotinic acid | C7H6ClNO2 | 1060810-03-8 | Details |
| 2-Methyl-1-(4-methylphenyl)propan-2-amine | C11H17N | 67510-95-6 | Details |
| 4-[(Phenylamino)methyl]phenol hydrochloride | C13H14ClNO | 6337-84-4 | Details |
| 4-[(4-Chloro-1H-pyrazol-1-yl)methyl]-5-methylthiophene-2-carbaldehyde | C10H9ClN2OS | 1006448-83-4 | Details |
| 1-(2-Cyclopropyl-1,3-oxazol-4-yl)ethan-1-one | C8H9NO2 | 1519375-49-5 | Details |
| Pyrrolam A | C7H9NO | 113727-94-9 | Details |
| (3-Chloro-phenyl)-acetic acid hydrazide | C8H9ClN2O | 66464-86-6 | Details |
| 2,3-dimethyl-1-phenyl-4-((phenylsulfonyl)amino)-3-pyrazolin-5-one | C17H17N3O3S | 4392-43-2 | Details |
| Topotecan hydrochloride | C23H24ClN3O5 | 119413-54-6 | Details |
| Methyl 4-amino-1-ethyl-3-methyl-1H-pyrazole-5-carboxylate | C8H13N3O2 | 210163-95-4 | Details |
| 2-Ethyl-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}pyrrolidine-2-carboxylic acid | C22H23NO4 | 1549438-52-9 | Details |
| 3-(Acetamidomethyl)benzoic acid | C10H11NO3 | 777-69-5 | Details |
| H-Arg-Arg-Lys-Asp-Leu-His-Asp-Asp-Glu-Glu-Asp-Glu-Ala-Met-Ser-Ile-Thr-Ala-OH | C85H139N27O35S | 154444-97-0 | Details |
| 2-(2-Oxoimidazolidin-1-yl)acetic acid | C5H8N2O3 | 87219-22-5 | Details |
| 6-Deoxy-6-thio-a-cyclodextrin | C36H60O24S6 | 180839-60-5 | Details |
| 1-(4-Nitro-benzenesulfonyl)-piperidine-4-carboxylic acid | C12H14N2O6S | 331828-49-0 | Details |
| MRPL24 antibody | Details |
| Etazolate hydrochloride | C14H18N5O2HCl | 35838-58-5 | Details |
| Icarisid II - Bio-X ™ | C27 H30 O10 | 113558-15-9 | Details |
| SLC6A15 Blocking Peptide | Details |
| Cis-mulberroside A | C26H32O14 | 166734-06-1 | Details |
| 2-(2,6-dimethyl-3,6-dihydro-2H-pyran-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C13H23BO3 | 1394909-88-6 | Details |
| 8-(3,5-Diethyl-1H-pyrazol-1-yl)-3,7-dimethyl-1H-purine-2,6(3H,7H)-dione | C14H18N6O2 | 1014031-70-9 | Details |
| N-(2-Aminoethyl)-N-methylthiophene-2-sulfonamide hydrochloride | C7H13ClN2O2S2 | 1423025-69-7 | Details |
| 2-[4-(3,4-Dichlorophenyl)-1,3-thiazol-2-yl]acetonitrile | C11H6Cl2N2S | 637015-80-6 | Details |
| 2,4-Anhydro-L-ribonic acid methyl ester | C6H10O5 | 1038922-16-5 | Details |
| Valsartan - Bio-X ™ | C24H29N5O3 | 137862-53-4 | Details |
| 1-[3-(Trifluoromethyl)phenyl]imidazolidin-2-one | C10H9F3N2O | 14088-95-0 | Details |
| Diphenyl-1,2-oxazol-5-amine | C15H12N2O | 52392-73-1 | Details |
| 3-[1-Butyl-5-(pyrrolidine-1-sulfonyl)-1H-1,3-benzodiazol-2-yl]propanoic acid | C18H25N3O4S | 790681-55-9 | Details |
| T 82 | C30H33N3O6 | 252264-92-9 | Details |
| N-[(4-Methylmorpholin-2-yl)methyl]-1,3-thiazol-2-amine | C9H15N3OS | 1423035-13-5 | Details |
| Cucurbitacin I - Bio-X ™ | C30H42O7 | 2222-07-3 | Details |
| Ficlatuzumab | 1174900-84-5 | Details |
| Zoledronic acid monohydrate - Bio-X ™ | C16H22ClN3 | 154-69-8 | Details |
| AZD 3988 | C23H22F2N4O4 | 892489-52-0 | Details |
| 4'-Bromo-3'-(trifluoromethyl)acetophenone | C9H6BrF3O | 120077-70-5 | Details |
| ALDH4A1 antibody | Details |
| MEA1 antibody | Details |
| ACCN5 antibody | Details |
| rac-(1R,3S)-3-Aminocyclopentane-1-carbonitrile hydrochloride | C6H11ClN2 | 2216759-16-7 | Details |
| Etonogestrel | C22H28O2 | 54048-10-1 | Details |
| Edoxaban impurity G | C24H30ClN7O4S | 1255529-26-0 | Details |
| 5-Bromofuran-2-sulfonyl fluoride | C4H2BrFO3S | 2137682-74-5 | Details |
| rac-(2R,6R)-1-[(tert-Butoxy)carbonyl]-6-methylpiperidine-2-carboxylic acid | C12H21NO4 | 2166006-41-1 | Details |
| Iguratimod - Bio-X ™ | C17H14N2O6S | 123663-49-0 | Details |
| 2'-Deoxy-L-guanosine | C10H13N5O4 | 22837-44-1 | Details |
| 4-chloro-2-nitro-N-(2-phenylethyl)benzene-1-sulfonamide | C14H13ClN2O4S | 1023875-76-4 | Details |
| (R)-4-(2,4-Dimethoxybenzyl)-3-methylpiperazin-2-one | C14H20N2O3 | 1383146-20-0 | Details |
| 2,2,3,3,4,4-Hexafluorobutyric acid | C4H2F6O2 | 679-12-9 | Details |
| HER-2 substrate peptide | Details |
| 2-Methyl-5-(1-methyl-1H-imidazole-5-carbonyl)pyridine | C11H11N3O | 288392-21-2 | Details |
| N-{3-[(3-Bromopyridin-2-yl)amino]phenyl}acetamide | C13H12BrN3O | 1293156-74-7 | Details |
| Myosin 9 antibody (HRP) | Details |
| VPS26A Blocking Peptide | Details |
| RBL2 antibody | Details |
| (4-Cyclopropyl-2-fluorophenyl)methanamine | C10H12FN | 1248106-66-2 | Details |
| Lidocaine antibody | Details |
| FBXO24 Blocking Peptide | Details |
| Methyl 5-(chlorosulfonyl)naphthalene-1-carboxylate | C12H9ClO4S | 141952-09-2 | Details |
| HSV1 antibody (biotin) | Details |
| 1-(2,4-Dichlorophenyl)-3-methyl-1H-pyrazol-5-amine | C10H9Cl2N3 | 81198-25-6 | Details |
| 3-(2,2-Difluoroethoxy)propanoic acid | C5H8F2O3 | 1545306-92-0 | Details |
| 3'-O-Benzoylthymidine | C17H18N2O6 | 17331-53-2 | Details |
| 1-(1-Benzofuran-2-yl)-3-(morpholin-4-yl)propan-1-one hydrochloride | C15H18ClNO3 | 15817-89-7 | Details |
| (4-Bromo-1,3-oxazol-2-yl)methanol | C4H4BrNO2 | 1240615-29-5 | Details |
| Brain Natriuretic Peptide(BNP,Porcine,1-26) Antiserum | Details |
| tert-Butyl 4-(3-bromo-2-oxopropyl)piperidine-1-carboxylate | C13H22BrNO3 | 473795-43-6 | Details |
| 4-Cyclopropyl-7H-pyrrolo[2,3-d]pyrimidine | C9H9N3 | 1318945-19-5 | Details |
| ABCC12 antibody | Details |
| Hydromorphone-HRP | Details |
| α-N-Acetylglucosaminidase | 37288-40-7 | Details |
| 1-Isothiocyanato-4-(propan-2-yloxy)benzene | C10H11NOS | 50785-46-1 | Details |
| PQBP1 antibody | Details |
| 1-(((4-((5-chloro-2-methoxyphenyl)amino)(3,5-thiazolyl))methyl)sulfonyl)-4-methylbenzene | C18H17ClN2O3S2 | 1119392-32-3 | Details |
| 3-Cyclopropylcyclobutane-1-carboxylic acid | C8H12O2 | 1784150-06-6 | Details |
| TROVE2 antibody | Details |
| {1-Oxaspiro[4.4]nonan-2-yl}methanol | C9H16O2 | 129055-62-5 | Details |
| 2-[(Dimethylamino)methyl]cyclohexan-1-ol | C9H19NO | 17589-70-7 | Details |
| 2-[2-(3-Amino-1H-pyrazol-1-yl)ethoxy]ethan-1-ol | C7H13N3O2 | 1248122-01-1 | Details |
| H-WFSAGLASNSSWLR-OH | Details |
| N-Acetyl-9-O-(N-acetyl-a-neuraminosyl)-neuraminic acid | C22H36N2O17 | 96425-77-3 | Details |
| Ethyl 2,4-dihydroxy-6-methylnicotinate | C9H11NO4 | 10350-10-4 | Details |
| H-SITSAVLQSGFRKMA-OH | Details |
| 2-(3-Amino-1H-pyrazol-1-yl)-6-fluorobenzonitrile | C10H7FN4 | 1249650-30-3 | Details |
| H-GDVAFVK-OH | Details |
| PRDX2 Blocking Peptide | Details |
| C10ORF56 Blocking Peptide | Details |
| 2-Bromo-1-(1H-indol-3-yl)propan-1-one | C11H10BrNO | 19620-87-2 | Details |
| Product Total： Product Page： | ||||
| 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||